We are live on ! Find out more
EV

Eclipse Ventures Portfolio holdings

AUM $2.57B
This Fund
S&P 500
This Quarter Est. Return
+85.85%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$268M
AUM Growth
+$51.2M
Cap. Flow
-$84.4M
Cap. Flow %
-31.5%
Top 10 Hldgs %
100%
Holding
3
New
Increased
Reduced
1
Closed

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
ENVX icon
Enovix
ENVX
+$84.4M

Sector Composition

Rank Sector Weight
1 Industrials 86.16%
2 Healthcare 13.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ENVX icon
1
Enovix
ENVX
$737M
$231M 86.16%
14,380,866
-5,714,286
-28% -$84.4M
OWLT icon
2
Owlet
OWLT
$146M
$30.5M 11.38%
2,035,167
LHDX
3
DELISTED
Lucira Health, Inc. Common Stock
LHDX
$6.6M 2.46%
6,223,795

Similar funds

Eclipse Ventures's Q3 2022 Portfolio in Review

As of Q3 2022, Eclipse Ventures held 3 positions worth $268M, up 24% from $217M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Eclipse Ventures withdrew a net $84.4M in Q3 2022, reducing 1 holding. Its largest reduction was Enovix, cutting an estimated $84.4M.

By sector, the portfolio is most concentrated in Industrials at 86% of assets, up from 72% a quarter earlier, followed by Healthcare.

  • Eclipse Ventures's biggest Q3 2022 reduction was Enovix, cutting an estimated $84.4M.
  • Eclipse Ventures's ten largest holdings make up 100% of its $268M portfolio in Q3 2022.
  • Eclipse Ventures opened 0 new positions and closed 0 in Q3 2022.
  • Eclipse Ventures's portfolio value rose 24% quarter-over-quarter to $268M.

Based on Eclipse Ventures's 13F filing for Q3 2022, filed 14 Nov 2022.